Remember how urgent it was to support embryonic stem cell research? That was then; this is now
by Michael Cook | 4 Oct 2020 |
The hot button bioethical issue of 2004 was embryonic stem cell research. Supporters spoke of life-saving cures and dismissed ethical misgivings. Surfing a wave of hope, Californian voters voted for a US$3 billion bond issue to establish the California Institute for Regenerative Medicine.
Sixteen years later, the CIRM has almost run out of money and its backers are rattling the tin in the hope that voters will approve a $5.5 billion bond issue to support its research.
Some of the state’s major newspapers have editorialised against it. With many of its critics, they contend that the CIRM has not delivered on its miracle cures, that its governance has been poor and that there was too much potential for conflict of interest.
The Los Angeles Times decried the earlier over-sell:
“[The CIRM] hasn’t yet yielded a significant financial return on investment for the state — or the cures that were ballyhooed at the time. Though no one ever promised quick medical miracles, campaign ads strongly implied they were around the corner if only the funding came through. Proponents oversold the initiatives and voters can’t be blamed if they view this new proposal with skepticism.”
The San Francisco Chronicle, which exposed some of the CIRM’s deficiencies in a 2018 exposé, criticised the way its funds had been spent:
“More than half the original funding went to buildings and other infrastructure, education and training, and the sort of basic research that, while scientifically valuable, is a long way from medical application. There’s nothing inherently wrong with that, but it is at odds with the vision of dramatic advancements put to voters."
Michael Cook is editor of BioEdge
These are strange, strange times. Today I read an editorial in The New York Times headed, “Get Well, Mr. President”. I don’t recall ever reading words of personal concern like this before in the Times. It was very touching.
But, of course, the editorial’s theme was not only wishing him and the First Lady well, but demanding complete transparency about his health now that he has been infected with the coronavirus. We’ll be hearing a lot more about every detail of Mr Trump’s life in the next few days.
Speaking of which, I shall be taking a brief holiday this week. The next BioEdge newsletter will be on October 18.
Cheers,
Michael Cook
Editor
But, of course, the editorial’s theme was not only wishing him and the First Lady well, but demanding complete transparency about his health now that he has been infected with the coronavirus. We’ll be hearing a lot more about every detail of Mr Trump’s life in the next few days.
Speaking of which, I shall be taking a brief holiday this week. The next BioEdge newsletter will be on October 18.
Cheers,
Michael Cook
Editor
by Michael Cook | Oct 04, 2020
Should he have access to experimental medicines?by Michael Cook | Oct 04, 2020
New Zealand, Massachusetts, Portugal, Austria, Ireland, Tasmaniaby Michael Cook | Oct 04, 2020
Britain’s biggest serial killer was a family doctorby Michael Cook | Oct 04, 2020
“People like me are endangered and now they want to make me extinct.”by Michael Cook | Oct 04, 2020
Stanford epidemiologist John P.A. Ioannides says no.by Michael Cook | Oct 04, 2020
The British Pregnancy Advisory Service is going to open an IVF clinicby Michael Cook | Oct 04, 2020
California Institute for Regenerative Medicine goes back to the votersby Michael Cook | Oct 04, 2020
Would the founder of utilitarianism support Covid-19 directives? BioEdge
L1, Unit 7, 11 Lord Street · Botany, NSW 2019 · Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615
.png)
No hay comentarios:
Publicar un comentario